Lumexa Imaging Holdings, a diagnostic imaging provider with 184 outpatient centers across the US, raised $463 million by offering 25 million shares at $18.5, within the range of $17 to $20. The company is coming public with a market cap of $1.8 billion and an enterprise value of $2.6 billion.
Lumexa is a national provider of outpatient diagnostic imaging services, operating 184 centers across 13 states through a mix of wholly owned sites and joint ventures with health systems. The company offers a range of advanced and routing imaging modalities, spanning MRIs, CTs, PET scans, X-rays, ultrasounds, and mammograms. The company booked $1.0 billion in sales for the 12 months ended September 30, 2025.
Lumexa Imaging Holdings plans to list on the Nasdaq under the symbol LMRI. Barclays, J.P. Morgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James acted as joint bookrunners on the deal.
